Cleared Traditional

K110277 - RAPIDPOINT 405 NEONATAL BILIRUBIN (FDA 510(k) Clearance)

Aug 2011
Decision
196d
Days
Class 1
Risk

K110277 is an FDA 510(k) clearance for the RAPIDPOINT 405 NEONATAL BILIRUBIN. This device is classified as a Bilirubin (total And Unbound) In The Neonate Test System (Class I - General Controls, product code MQM).

Submitted by Siemens Healthcare Diagnostics (Norowood, US). The FDA issued a Cleared decision on August 15, 2011, 196 days after receiving the submission on January 31, 2011.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1113.

Submission Details

510(k) Number K110277 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 31, 2011
Decision Date August 15, 2011
Days to Decision 196 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code MQM — Bilirubin (total And Unbound) In The Neonate Test System
Device Class Class I - General Controls
CFR Regulation 21 CFR 862.1113